• So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2020 Financial Results

    Source: Nasdaq GlobeNewswire / 22 Mar 2021 04:10:00   America/Chicago

    BEIJING, China, March 22, 2021 (GLOBE NEWSWIRE) -- So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.

    Fourth Quarter 2020 Financial Highlights

    • Total revenues were RMB424.6 million (US$65.1 million1), an increase of 18.6% from RMB358.2 million in the same period of 2019, in line with our previous guidance.

    • Net income was RMB37.7 million (US$5.8 million), compared with a net income RMB69.9 million in the same period of 2019.

    • Non-GAAP net income2 was RMB62.2 million (US$9.5 million), compared with a non-GAAP net income of RMB86.4 million in the same period of 2019.

    Fourth Quarter 2020 Operational Highlights

    • Average mobile MAUs were 8.9 million, an increase of 142.3% from 3.7 million in the fourth quarter of 2019.

    • Total number of users purchasing reservation service were 194,769 and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young’s platform was RMB969.3 million.

    • Number of paying medical service providers on So-Young’s platform were 4,746, an increase of 40.5% from 3,378 in the fourth quarter of 2019.

    Fiscal Year 2020 Financial Highlights

    • Total revenues were RMB1,295.0 million (US$198.5 million) in the full year 2020, an increase of 12.4% from RMB1,151.6 million in the prior year.

    • Net income was RMB4.9 million (US$0.7 million) in the full year 2020, compared with a net income RMB176.7 million in the prior year.

    • Non-GAAP net income was RMB97.0 million (US$14.9 million) in the full year 2020, compared with a non-GAAP net income of RMB280.9 million in the prior year.

    Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, “We ended a very challenging year of 2020 with a solid quarter of growth in-line with our guidance. During the past year, we successfully carried out key initiatives that continued to fully leverage our high-quality content, robust technology, and the years of trust we have built with users and medical service providers in China. Strong user growth momentum continued in the fourth quarter due to the expansion of our content library and the launch of innovative services such as “VR Store” and “Live Diagnosis”. In the fourth quarter of 2020, the average mobile MAUs reached 8.9 million, an increase of 142.3% from the same period in 2019, and the number of paying medical service providers on So-Young’s platform were 4,746, up 40.5% year-over-year.”

    Mr. Jin continued, “Looking at 2021, we are continuously enhancing our community-based content offerings to address different needs from the enlarged pool of users, especially those who are core consumers for medical aesthetic services. On the business front, we will continue to solidify our advantages in plastic surgery, which has been traditionally our strength while we will also capture the tremendous opportunities in non-surgical categories which will continue their strong growth in the coming year. Lastly, we will continue to upgrade our products and services and improve user experience. Looking forward into the future, we will fully leverage our competitive edges in content offering, technology and user base, be user-centric, deeply explore the medical aesthetic industrial chain, and become the most trusted platform in the broader consumption healthcare service industry starting from aesthetics.”

    Mr. Min Yu, Chief Financial Officer of So-Young, also commented, “Total revenues for the fourth quarter were RMB424.6 million, up 18.6% year-over-year, primarily due to an increase in the number of paying medical service providers on the platform. We also maintained our gross margin at 85.0% in the fourth quarter of 2020, compared to 83.7% in the same period last year, reflecting the ongoing optimization of our business model and effective cost control measures. Going forward, we are confident that we are on track to fully recover from the impact of the COVID-19 pandemic and continuously deliver long-term value to our shareholders.”

    Fourth Quarter 2020 Financial Results

    Revenues

    Total revenues were RMB424.6 million (US$65.1 million), an increase of 18.6% from RMB358.2 million in the same period of 2019. The increase was primarily due to an increase in the number of paying medical service providers which gradually recovered operation as the COVID-19 pandemic has become more controlled in China.

    • Information services revenues were RMB335.9 million (US$51.5 million), an increase of 27.0% from RMB264.5 million in the same period of 2019. The increase was mainly due to an increase in average revenue per paying medical service provider. Total number of paying medical service providers subscribing to information services on So-Young’s platform was 2,239 during the quarter.

    • Reservation services revenues were RMB88.7 million (US$13.6 million), a decrease of 5.3% from RMB93.7 million in the same period of 2019. The decrease was primarily because surgical transactions were still gradually recovering to the peak season of last year before the Covid-19 pandemic.

    Cost of Revenues

    Cost of revenues were RMB63.6 million (US$9.8 million), an increase of 8.7% from RMB58.5 million in the fourth quarter of 2019. Cost of revenues included share-based compensation expenses of RMB5.0 million (US$0.8 million) during the fourth quarter of 2020, compared with RMB4.1 million in the corresponding period of 2019.

    Operating Expenses

    Total operating expenses were RMB331.2 million (US$50.8 million), an increase of 48.6% from RMB222.9 million in the fourth quarter of 2019.

    • Sales and marketing expenses were RMB210.4 million (US$32.2 million), an increase of 59.2% from RMB132.2 million in the fourth quarter of 2019. The increase was primarily due to an increase in expenses associated with marketing activities and payroll costs. Sales and marketing expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB2.2 million (US$0.3 million), compared with RMB2.4 million in the corresponding period of 2019.

    • General and administrative expenses were RMB49.9 million (US$7.6 million), an increase of 38.4% from RMB36.0 million in the fourth quarter of 2019. The increase was primarily due to an increase in payroll costs associated with the expansion of administrative employees. General and administrative expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB11.3 million (US$1.7 million), compared with RMB5.1 million in the corresponding period of 2019.

    • Research and development expenses were RMB70.9 million (US$10.9 million), an increase of 29.6% from RMB54.7 million in the fourth quarter of 2019. The increase was primarily attributable to an increase in payroll costs. Research and development expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB5.9 million (US$0.9 million) , compared with RMB4.9 million in the corresponding period of 2019.

    Income Tax Expenses

    Income tax expenses were RMB13.0 million (US$2.0 million), compared with RMB29.0 million income tax expenses in the same period of 2019. The change was mainly due to the decrease in taxable income.

    Net income

    Net income was RMB37.7 million (US$5.8 million), compared with a net income RMB69.9 million in the fourth quarter of 2019.

    Non-GAAP net income

    Non-GAAP net income, which excludes the impact of share-based compensation expenses, was RMB62.2 million (US$9.5 million), compared with RMB86.4 million non-GAAP net income in the same period of 2019.

    Basic and Diluted Earnings per ADS

    Basic and diluted earnings per ADS attributable to ordinary shareholders were RMB0.36 (US$0.06) and RMB0.35 (US$0.05), compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB0.68 and RMB0.65 in the same period of 2019.

    Fiscal Year 2020 Financial Results

    Revenues

    Total revenues were RMB1,295.0 million (US$198.5 million), an increase of 12.4% from RMB1,151.6 million in fiscal year 2019.

    • Information services revenues were RMB962.1 million (US$147.4 million), an increase of 15.4% from RMB833.4 million in fiscal year 2019. The increase was primarily attributable to an increase in average revenue per medical service provider as they increasingly allocate a larger proportion of their marketing budgets to So-Young’s platform.
    • Reservation services revenues were RMB332.9 million (US$51.0 million), an increase of 4.6% from RMB318.2 million in fiscal year 2019. The increase was primarily due to an increase in the number of purchasing users.

    Cost of Revenues

    Cost of revenues were RMB212.2 million (US$32.5 million), an increase of 6.8% from RMB198.6 million in fiscal year 2019. The increase was primarily due to an increase in servers cost related to online platform development. In addition, cost of revenues for 2020 included share-based compensation expenses of RMB18.3 million (US$2.8 million) compared to RMB12.8 million in 2019.

    Operating Expenses

    Total operating expenses were RMB1,139.5 million (US$174.6 million), an increase of 41.1% from RMB807.8 million in fiscal year 2019.

    • Sales and marketing expenses were RMB726.3 million (US$111.3 million), an increase of 54.5% from RMB470.0 million in fiscal year 2019. The increase was primarily due to an increase in expenses associated with branding and marketing activities. Sales and marketing expenses for 2020 included share-based compensation expenses of RMB6.7 million (US$1.0 million), compared to RMB8.5 million in 2019.

    • General and administrative expenses were RMB184.0 million (US$28.2 million), an increase of 14.6% from RMB160.5 million in fiscal year 2019. This was primarily due to an increase in personnel related expenses. General and administrative expenses for 2020 included share-based compensation expenses of RMB46.0 million (US$7.1 million), compared to RMB61.6 million in 2019.

    • Research and development expenses were RMB229.2 million (US$35.1 million), an increase of 29.3% from RMB177.3 million in fiscal year 2019. The increase was primarily attributable to an increase in personnel related expenses. Research and development expenses for 2020 included share-based compensation expenses of RMB21.1 million (US$3.2 million), compared to RMB21.4 million in 2019.

    Income Tax (Expenses)/Benefit

    Income tax benefit was RMB4.8 million (US$0.7 million), compared with income tax expenses of RMB49.7 million in fiscal year 2019. The income tax benefit was derived from a change in the preferential income tax rate of one of So-Young’s subsidiaries, which resulted in a refund of RMB16.4 million for tax paid in previous periods.

    Net Income

    Net income was RMB4.9 million (US$0.7 million), compared with RMB176.7 million in fiscal year 2019.

    Non-GAAP net income

    Non-GAAP net income, which excludes the impact of share-based compensation expenses, was RMB97.0 million (US$14.9 million), compared to RMB280.9 million in fiscal year 2019.

    Basic and Diluted Earnings per ADS

    Basic and diluted earnings per ADS attributable to ordinary shareholders were RMB0.05 (US$0.01) and RMB0.05 (US$0.01), respectively, compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB1.64 and RMB1.54 in fiscal year 2019.

    Cash and Cash Equivalents, Restricted Cash and Term Deposits, Term Deposits and Short-Term Investments

    As of December 31, 2020, cash and cash equivalents, restricted cash and term deposits, term deposits and short-term investments were RMB2,676.0 million (US$410.1 million), compared with RMB2,844.0 million as of December 31, 2019.

    Business Outlook

    For the first quarter of 2021, So-Young expects total revenues to be between RMB320 million (US$49.0 million) and RMB330 million (US$50.6 million), representing a 75.3% to 80.8% increase from the same period in 2020. The above outlook is based on the current market conditions and reflects the Company’s preliminary estimates of market and operating conditions, and customer demand, particularly in view of the potential impact of the COVID-19, the effects of which are difficult to analyze and predict, which are all subject to change.

    Non-GAAP Financial Measures

    To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States, or GAAP, this press release presents non-GAAP income from operations and non-GAAP net income by excluding share-based compensation expenses from income from operations and net income, respectively. The Company believes these non-GAAP financial measures are important to help investors understand the Company’s operating and financial performance, compare business trends among different reporting periods on a consistent basis and assess the Company’s core operating results, as they exclude certain expenses that are not expected to result in cash payments. The use of the above non-GAAP financial measures has certain limitations. Share-based compensation expenses have been and will continue to be incurred in the future and are not reflected in the presentation of the non-GAAP financial measures, but should be considered in the overall evaluation of the Company’s results. The Company compensates for these limitations by providing the relevant disclosure of its share-based compensation expenses in the reconciliations to the most directly comparable GAAP financial measures, which should be considered when evaluating the Company’s performance. These non-GAAP financial measures should be considered in addition to financial measures prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measure is set forth at the end of this release.

    Conference Call Information
    So-Young’s management will hold an earnings conference call on Monday, March 22, 2021, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Participants can register for the conference call by navigating to http://apac.directeventreg.com/registration/event/2133378.

    Once preregistration has been completed, participants will receive dial-in numbers, an event passcode, and a unique registrant ID.

    To join the conference, please dial the number you receive, enter the event passcode followed by your unique registrant ID, and you will be joined to the conference instantly.

    A telephone replay will be available two hours after the conclusion of the conference call through 8:59 AM U.S. Eastern Time, March 30, 2021. The dial-in details are:

    International:+61-2-8199-0299
    US:+1-646-254-3697
    Passcode:2133378

    Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.

    About So-Young International Inc.
    So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”) is the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry. The Company presents users with reliable information through offering high quality and trustworthy content together with a multitude of social functions on its platform, as well as by curating medical aesthetic service providers that are carefully selected and vetted. Leveraging So-Young’s strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well-positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.

    Safe Harbor Statement
    This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Young’s strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about So-Young’s beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Young’s strategies; So-Young’s future business development, financial condition and results of operations; So-Young’s ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Young’s revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; the impact of the COVID-19 pandemic to So-Young’s business operations and the economy in China and elsewhere generally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.

    For more information, please contact:

    So-Young

    Investor Relations
    Ms. Vivian XU
    Phone: +86-10-8790-2012
    E-mail: ir@soyoung.com

    Christensen

    In China
    Mr. Eric Yuan
    Phone: +86-10-5900-1548
    E-mail: Eyuan@christensenir.com

    In US
    Ms. Linda Bergkamp
    Phone: +1-480-614-3004
    Email: lbergkamp@christensenir.com

    SO-YOUNG INTERNATIONAL INC.
    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
    (Amounts in thousands, except for share and per share data)

     As of
     December 31,
    2019    		 December 31,
    2020    		 December 31,
    2020
     RMB RMB US$
    Assets     
    Current assets:     
    Cash and cash equivalents884,676 1,127,055 172,729
    Restricted cash and term deposits16,509 21,865 3,352
    Trade receivables26,110 52,871 8,103
    Receivables from online payment platforms13,429 16,182 2,480
    Amounts due from related parties5,815 7,764 1,190
    Term deposits and short-term investments1,942,860 1,527,088 234,036
    Prepayment and other current assets67,628 43,190 6,619
    Total current assets2,957,027 2,796,015 428,509
    Non-current assets:     
    Long-term investments45,980 166,100 25,456
    Intangible assets726 60,029 9,200
    Goodwill- 48,500 7,433
    Property and equipment, net32,341 29,830 4,572
    Deferred tax assets35,208 55,520 8,509
    Operating lease right-of-use assets144,488 120,140 18,412
    Other non-current assets14,184 15,878 2,433
    Total non-current assets272,927 495,997 76,015
    Total assets3,229,954 3,292,012 504,524
          
    Liabilities     
    Current liabilities:     
    Taxes payable65,605 60,070 9,207
    Contract liabilities93,725 135,385 20,749
    Salary and welfare payables100,676 95,758 14,676
    Amounts due to related parties2,620 2,404 368
    Accrued expenses and other current liabilities166,088 237,785 36,442
    Operating lease liabilities-current37,799 39,468 6,049
    Total current liabilities466,513 570,870 87,491
    Non-current liabilities:     
    Operating lease liabilities-non current120,803 93,044 14,260
    Deferred tax liabilities- 8,522 1,306
    Total non-current liabilities120,803 101,566 15,566
    Total liabilities587,316 672,436 103,057
          
    Mezzanine equity     
    Redeemable non-controlling interests- 23,205 3,556
    Total mezzanine equity- 23,205 3,556
          


    SO-YOUNG INTERNATIONAL INC.
    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)
    (All amounts in thousands, except for share and per share data, unless otherwise noted)

    Shareholders’ equity:      
    Class A Ordinary shares (US$ 0.0005 par value; 750,000,000 shares authorized as of December 31, 2019 and December 31, 2020; 69,371,718 and 70,212,159 shares issued and outstanding as of December 31, 2019 and December 31, 2020, respectively)221  224  34  
    Class B Ordinary shares (US$ 0.0005 par value; 20,000,000 shares authorized as of December 31, 2019 and December 31, 2020; 12,000,000 shares issued and outstanding as of December 31, 2019 and December 31, 2020)37  37  6  
    Additional paid-in capital2,799,336  2,892,268  443,259  
    Statutory reserves10,562  10,562  1,619  
    Accumulated deficit(259,251) (254,228) (38,962) 
    Accumulated other comprehensive income/(loss)91,733  (52,492) (8,045) 
    Total shareholders’ equity2,642,638  2,596,371  397,911  
    Total liabilities, mezzanine equity and shareholders’ equity3,229,954  3,292,012  504,524  
              


    SO-YOUNG INTERNATIONAL INC.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
    (Amounts in thousands, except for share and per share data)

     For the Three Months Ended  For the Fiscal Year Ended
     December 31, 2019 December 31, 2020 December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2020
     RMB RMB US$ RMB RMB US$
                
    Revenues           
    Information services264,517  335,911  51,481  833,422  962,089  147,447 
    Reservation services93,657  88,724  13,597  318,215  332,899  51,019 
    Total revenues358,174  424,635  65,078  1,151,637  1,294,988  198,466 
    Cost of revenues(58,511) (63,620) (9,750) (198,630) (212,206) (32,522)
    Gross profit 299,663  361,015  55,328  953,007  1,082,782  165,944 
    Operating expenses:           
    Sales and marketing expenses(132,152) (210,378) (32,242) (470,033) (726,297) (111,310)
    General and administrative expenses(36,039) (49,888) (7,646) (160,531) (183,987) (28,197)
    Research and development expenses(54,709) (70,920) (10,869) (177,268) (229,192) (35,125)
    Total operating expenses(222,900) (331,186) (50,757) (807,832) (1,139,476) (174,632)
    Income/(loss) from operations76,763  29,829  4,571  145,175  (56,694) (8,688)
    Other income/(expenses):           
    Investment income4,144  3,130  480  8,698  13,599  2,084 
    Interest income13,517  6,753  1,035  45,045  39,669  6,080 
    Exchange gains/(losses)441  (603) (92) (3,235) (1,118) (171)
    Impairment of long-term investments(4,000) -  -  (4,000) -  - 
    Share of income/(losses) of equity method investee-  198  30  -  (4,279) (656)
    Others, net8,089  11,407  1,748  34,776  8,916  1,366 
    Income before tax98,954  50,714  7,772  226,459  93  15 
    Income tax (expenses)/benefit(29,009) (12,997) (1,992) (49,735) 4,784  733 
    Net income69,945  37,717  5,780  176,724  4,877  748 
    Net loss attributable to noncontrolling interests-  (930) (143) -  (930) (143)
    Net income attributable to So-Young International Inc.69,945  38,647  5,923  176,724  5,807  891 
    Accretions of convertible redeemable preferred shares to redemption value-  -  -  (50,219) -  - 
    Net income attributable to ordinary shareholders of the Company69,945  38,647  5,923  126,505  5,807  891 
                      

    SO-YOUNG INTERNATIONAL INC.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Continued)
    (Amounts in thousands, except for share and per share data)

     For the Three Months Ended For the Fiscal Year Ended
                
     December 31, 2019 December 31, 2020 December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2020
     RMB RMB US$ RMB RMB US$
                
    Net income per ordinary share           
    Net earnings per ordinary share attributable to ordinary shareholder - basic0.89  0.47  0.07  2.13  0.07  0.01 
    Net earnings per ordinary share attributable to ordinary shareholder - diluted0.84  0.46  0.07  2.00  0.07  0.01 
    Net earnings per ADS attributable to ordinary shareholders - basic (13 ADS represents 10 Class A ordinary shares)0.68  0.36  0.06  1.64  0.05  0.01 
    Net earnings per ADS attributable to ordinary shareholders - diluted (13 ADS represents 10 Class A ordinary shares)0.65  0.35  0.05  1.54  0.05  0.01 
    Weighted average number of ordinary shares used in computing earnings per share, basic*79,030,547  81,904,047  81,904,047  59,357,935  81,534,991  81,534,991 
    Weighted average number of ordinary shares used in computing earnings per share, diluted*82,942,043  84,108,250  84,108,250  63,309,091  83,781,406  83,781,406 
                
    Share-based compensation expenses included in:           
    Cost of revenues(4,052) (5,040) (772) (12,752) (18,327) (2,809)
    Sales and marketing expenses(2,369) (2,183) (335) (8,479) (6,711) (1,029)
    General and administrative expenses(5,074) (11,311) (1,733) (61,579) (46,001) (7,050)
    Research and development expenses(4,934) (5,943) (911) (21,401) (21,131) (3,238)
    * Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted. 
                      


    SO-YOUNG INTERNATIONAL INC.
    Reconciliation of GAAP and Non-GAAP Results
    (Amounts in thousands, except for share and per share data)

     For the Three Months Ended For the Fiscal Year Ended
     December 31, 2019 December 31, 2020 December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2020
     RMB RMB US$ RMB RMB US$
                
    GAAP income/(loss) from operations76,763 29,829 4,571 145,175 (56,694) (8,688)
    Add back: Shared-based compensation expenses16,429 24,477 3,751 104,211 92,170  14,126 
    Non-GAAP income from operations93,192 54,306 8,322 249,386 35,476  5,438 
                
    GAAP Net income69,945 37,717 5,780 176,724 4,877  748 
    Add back: Shared-based compensation expenses16,429 24,477 3,751 104,211 92,170  14,126 
    Non-GAAP net income86,374 62,194 9,531 280,935 97,047  14,874 
                  

    ______________

    1 This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB6.5250 to US$1.00, which was the U.S. dollars middle rate announced by the Board of Governors of the Federal Reserve System of the United States on December 31, 2020.

    2 Non-GAAP net income is defined as net income excluding share-based compensation expenses. See “Reconciliation of GAAP and Non-GAAP Results” at the end of this press release.


Share on,